GeneDx Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

65.99

-0.86 (-1.29%)

At close: May 01, 2025, 3:24 PM

-1.29% (1D)

Bid	51.05
Market Cap	1.88B
Revenue (ttm)	305.45M
Net Income (ttm)	-52.29M
EPS (ttm)	-1.94
PE Ratio (ttm)	-34.02
Forward PE	35.5
Analyst	Strong Buy

Ask	82.18
Volume	2,490,437
Avg. Volume (20D)	1,171,559
Open	71.36
Previous Close	66.85
Day's Range	63.75 - 71.44
52-Week Range	18.56 - 117.75
Beta	2.00

About WGS

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides scien...

Sector Healthcare

IPO Date Nov 4, 2020

Employees 1,000

Stock Exchange NASDAQ

Ticker Symbol WGS

Website http://www.genedx.com

Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for WGS stock is "Strong Buy." The 12-month stock price forecast is $80, which is an increase of 21.23% from the latest price.

Stock Forecasts

Earnings Surprise

New

GeneDx has released their quartely earnings on Apr 30, 2025:

Revenue of $87.11M exceeds estimates by $7.3M, with 39.56% YoY growth.

EPS of 0.27 exceeds estimates by 0.18, with 181.82% YoY growth.

Why Price Moved

1 day ago New

-42.85%

GeneDx Holdings shares are trading lower. The comp... Unlock content with Pro Subscription

1 month ago

+4.93%

GeneDx Holdings shares are trading higher after the company announced an indication expansion for its industry leading genetic testing to now include cerebral palsy.

News

1 day ago · seekingalpha.com

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

GeneDx Holdings Corp. (NASDAQ:WGS ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Sabrina Dunbar - Investor Relations Katherine Stueland - Chief Executive Officer Kev...

1 day ago · fool.com

Why GeneDx Holdings Stock Is Plunging Today

Shares of GeneDx Holdings (WGS -39.70%) were plunging 42.9% as of 11:21 a.m. ET on Wednesday.

22 hours ago · zacks.com

GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates

GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to loss of $0.33 per share a year ago.

1 day ago · businesswire.com

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2025.

2 days ago · zacks.com

GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why

GENEDX HOLDINGS (WGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 days ago · seekingalpha.com

GeneDx: Strengthening Leadership In Genomic Diagnostics

GeneDx Holdings Corp. leverages genomic sequencing and data science for early diagnosis and treatment, focusing on pediatric outpatient and neonatal ICU settings. GeneDx will report Q1 2025 earnings o...

1 week ago · zacks.com

Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?

GeneDx is expected to have continued the strong 2024 momentum across all metrics in the first quarter of 2025.

2 weeks ago · businesswire.com

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

GAITHERSBURG, Md. & OAKLAND, Calif.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation.

3 weeks ago · businesswire.com

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced it will release financial results for the first quarter of 2025 before the market opens on Wednesday, April 30, 2025.

4 weeks ago · zacks.com

Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff Threats

GME, WGS and APP are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Load More News